Clinical Trials · NCT02773355
Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 27
- Start date
- May 2016
- Locations
- 14 sites, Mexico
- Primary endpoint
- Frequency of pancreatitis